BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 7, 2013
View Archived Issues
Proof-of-concept demonstration of functional regeneration via stem-cell organ bud transplantation
Read More
to-BBB Holding presents promising phase I results for new oncolytic agent
Read More
Novel furin inhibitors patented
Read More
Axikin presents novel MAP3K19 inhibitors
Read More
Bayer discloses new TTK inhibitors for cancer
Read More
Lupin reports novel MEK inhibitors
Read More
Isis Pharmaceuticals reaches milestone in phase II study in spinal muscular atrophy
Read More
Synergy Pharmaceuticals begins phase II study of SP-333
Read More
KB-3944, a promising new drug for multiple sclerosis
Read More
Puma Biotechnology begins phase II trial of PB-272 in HER2 solid tumors
Read More
PharmAkea Therapeutics and Celgene to advance therapies for cancer and fibrotic disease
Read More
Targeting LINGO1, a promising therapeutic strategy for multiple sclerosis
Read More
Phase Ib/II study of Erivedge begins in relapsed/refractory AML and high-risk MDS
Read More
MRC Technology and Renishaw Diagnostics collaborate on diagnostics for infectious disease
Read More
MJFF grant supports Durin Technologies' blood test for Parkinson's disease
Read More
European submission to broaden label for Arzerra to include first-line CLL
Read More
Cognoptix demonstrates potential of Sapphire II eye test to identify patients with Alzheimer's
Read More
Astellas and Mitokyne establish R&D collaboration for mitochondria-related disorders
Read More
ETC and Debiopharm establish oncology research collaboration
Read More
PeptiDream and Ipsen expand collaboration
Read More
MorphoSys completes phase I/IIa study of MOR-208 in CLL
Read More
Amplimmune acquisition strengthens MedImmune's oncology pipeline
Read More
Safety and efficacy of INCB-039110 confirmed in patients with psoriasis
Read More
Axiron testosterone replacement therapy approved in Germany
Read More
Researchers present phase I results for the anti-IL-31 receptor antibody CIM-331
Read More